Press release
New Product Launches are driving the Immunoassay Market
The global immunoassay market is anticipated to grow at a CAGR of 6.08% during the forecast period (2024-2031). The market growth is driven by the growing number of diseases. The market is segmented by product (analyzer and consumable), technology (radioimmunoassay, counting immunoassay, enzyme immunoassays, fluoroimmunoassay, and chemiluminescence immunoassay), and geography (North America, Europe, Asia-Pacific, and the Rest of the World).Get Free Sample link @ https://www.omrglobal.com/request-sample/immunoassay-market
Market Dynamics
· In December 2024, Roche received CE mark approval for its cobas® Mass Spec solution, which includes the cobas® i 601 analyzers and an Ionify® reagent pack of four assays for steroid hormones.
· In August 2024, Wondfo presented new products at the 76th Annual American Congress of Clinical Chemistry and Exposition of Clinical Laboratory Medicine (ADLM). The products included the new fully automatic chemiluminescence immunoassay analyzer FC-2100, the fluorescence immunoassay analyzer Finecare™ FIA Meter X1 and X2, and the automatic blood gas analyzer Ucare-6000. The immunoassay analyzer covers 0.64 sqm, and the test speed is up to 200T/h. The first result shows within 12 minutes.
· In March 2024, Sysmex Corp. launched six testing parameters, including, HISCL LH Assay Kit, HISCL FSH Assay Kit, HISCL Prolactin Assay Kit, HISCL Estradiol Assay Kit, HISCL Progesterone Assay Kit, and HISCL Testosterone Assay Kit. The parameters will be applied to gynecological and gonadal hormone immunoassay panels in Japan. The testing parameters are applicable for Automated Immunoassay System HISCL-5000/HISCL-800 (HISCL-Series) and will address a wide range of laboratory needs.
· In January 2024, Fujirebio Holdings, Inc. and Agappe Diagnostics Ltd entered into a Contract Development and Manufacturing Organization (CDMO) partnership for a Cartridge-based CLIA system reagents manufacturing project. The project is aimed at manufacturing immunology equipment Mispa i60 and Mispa i121. The analyzers and reagents are sold under Agappe's brand.
· In July 2023, the Atellica CI Analyzer by Siemens Healthineers received FDA clearance. The product is available for immunoassay and clinical chemistry testing in major markets, globally.
· In September 2022, Spear Bio presented its immunoassay technology at the American Association of Clinical Chemistry's scientific meeting and clinical lab expo, in Chicago. The company unveiled the NAB-Sure™ SARS-CoV-2 neutralizing antibody (NAb) test kit. The product is useful against COVID-19 and serves various applications including COVID-19 serosurveillance, vaccine efficacy testing, and longitudinal antibody durability testing.
· In October 2022, Roche launched SARS-CoV-2 rapid antigen tests ("2.0") for COVID-19 test, for professional use (SARS-CoV-2 Rapid Antigen Test 2.0 (nasopharyngeal sampling), SARS-CoV-2 Rapid Antigen Test 2.0 Nasal (nasal sampling)) and self-testing (SARS-CoV-2 Antigen Self-Test Nasal (nasal sampling)).
Inquiry Before Buying of Immunoassay Market Report @ https://www.omrglobal.com/inquiry-before-buying/immunoassay-market
SARS-CoV-2 Rapid Antigen Test 2.01 (nasopharyngeal sampling) is a rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 in human nasopharyngeal swab samples.
SARS-CoV-2 Rapid Antigen Test 2.0 Nasal2 (nasal sampling) is a rapid chromatographic immunoassay for the qualitative detection of the nucleocapsid protein of SARS-CoV-2 present in human nasal swab samples.
SARS-CoV-2 Antigen Self-Test Nasal3 is for the qualitative detection of SARS-CoV-2 nucleocapsid antigen in human nasal samples.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Information or Query, Visit @ https://www.omrglobal.com/industry-reports/immunoassay-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release New Product Launches are driving the Immunoassay Market here
News-ID: 3816498 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for HISCL
Next-Gen Coagulation Monitoring Products Market 2025-2033 for Cardiovascular Car …
The Global Coagulation Monitoring Products Market reached US$ 4.82 billion in 2024 and is expected to reach US$ 7.81 billion by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.
Coagulation Monitoring Products Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and…
Chemiluminescence Immunoassay Market worth $19.0 billion by 2028
Browse 181 market data Tables and 52 Figures spread through 283 Pages and in-depth TOC on "Chemiluminescence Immunoassay Market by Product (Instrument, Consumable), Technology (Chemiluminescence Enzyme, Microparticle Chemiluminescence), Sample (Blood, Urine), Application (Infectious Disease, Oncology), End User - Global Forecast to 2028
Chemiluminescence Immunoassay Market [https://www.marketsandmarkets.com/Market-Reports/chemiluminescence-immunoassay-clia-market-131865271.html?utm_source=abnewswire.com&utm_medium=chemiluminescenceimmunoassaymarket] in terms of revenue was estimated to be worth $13.2 billion in 2023 and is poised to reach $19.0 billion by 2028, growing at a…
Chemiluminescence Immunoassay Market Is Projected To Reach USD 19.34 Billion by …
Chemiluminescence immunoassay (CLIA) has emerged as a pivotal technique in the field of medical diagnostics, providing sensitive and specific detection of various analytes in clinical samples. This market has witnessed significant growth in recent years due to its high throughput, accuracy, and versatility across multiple applications in healthcare. In this comprehensive overview, we delve into key points, trends, and recent industry news shaping the chemiluminescence immunoassay market. Chemiluminescence Immunoassay Market…
Chemiluminescence Immunoassay Market worth $19.0 billion | F. Hoffmann-La Roche …
Chemiluminescence Immunoassay Market in terms of revenue was estimated to be worth $13.2 billion in 2023 and is poised to reach $19.0 billion by 2028, growing at a CAGR of 7.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. Growth in the chemiluminescence immunoassay market is mainly driven by the growing prevalence of chronic diseases, Advancements in improving chemiluminescence immunoassay technologies in recent years, rising demand for…
Global Sepsis Diagnostics Market Size, Share, Trends and Forecast To 2019-2025
The global sepsis diagnostics market is estimated to grow at a significant CAGR during the forecast period. Sepsis is a major unmet medical need caused by a patient’s overwhelming and life-threatening immune response to infection and can lead to tissue damage, organ failure, and even death. Sepsis affects an estimated 20-30 million people globally every year. According to the Agency for Healthcare Research and Quality, sepsis is the most expensive…
Immunofluorescence Analyzer Market Witness Significant Growth | Abbott Laborator …
The advantages of a fluorescent detection system include higher sensitivity recognition of an analyte, simpler assay designs, and simplified reagents. Over the past few decades various advancements such as portability, compactness and real time monitoring of analyzer have supported the application of fluorescent-based immunoassay system in point-of-care. A modern immunofluorescence assay-based analyzer uses a florescent compound that absorbs light energy at a specific wavelength and emits energy at a different…